AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa ...
Standing has gained popularity among people looking to offset the harms of a sedentary lifestyle often caused by spending long days sitting in front of the computer, television or driving wheel.
The N.C. Department of Health and Human Services is reporting the first flu-related death of the 2024-25 flu season. An adult in the Charlotte metropolitan area died due to complications ...